期刊文献+

Occult hepatitis C virus infection in the Middle East and Eastern Mediterranean countries:A systematic review and meta-analysis 被引量:1

下载PDF
导出
摘要 BACKGROUND The presence of hepatitis C virus(HCV)RNA in liver tissue or peripheral blood mononuclear cells with no identified virus genome in the serum has been reported worldwide among patients with either normal or elevated serum liver enzymes.The characterization of occult HCV infection(OCI)epidemiology in the Middle East and Eastern Mediterranean(M and E)countries,a region with the highest incidence and prevalence rates of HCV infection in the world,would be effective for more appropriate control of the infection.AIM To estimate the pooled prevalence of OCI in M and E countries using a systematic review and meta-analysis.METHODS A systematic literature search was performed using international,regional and local electronic databases.Some conference proceedings and references from bibliographies were also reviewed manually.The search was carried out during May and June 2020.Original observational surveys were considered if they assessed the prevalence of OCI among the population of M and E countries by examination of HCV nucleic acid in peripheral blood mononuclear cells in at least 30 cases selected by random or non-random sampling methods.The meta-analysis was performed using Comprehensive Meta-analysis software based on heterogeneity assessed by Cochran’s Q test and I-square statistics.Data were considered statistically significant at a P value<0.05.RESULTS A total of 116 non-duplicated citations were found in electronic sources and grey literature.A total of 51 non-overlapping original surveys were appraised,of which 37 met the inclusion criteria and were included in the analysis.Data were available from 5 of 26 countries including Egypt,Iran,Pakistan,Saudi Arabia,and Turkey.The overall prevalence rate of OCI was estimated at 10.04%(95%CI:7.66%-13.05%).The lowest OCI rate was observed among healthy subjects(4.79%,95%CI:2.86%-7.93%).The higher rates were estimated for patients suffering from chronic liver diseases(12.04%,95%CI:5.87%-23.10%),and multi-transfused patients(8.71%,95%CI:6.05%-12.39%).Subgroup analysis indicated that the OCI rates were probably not associated with the studied subpopulations,country,year of study,the detection method of HCV RNA,sample size,patients’HCV serostatus,and sex(all P>0.05).Meta-regression analyses showed no significant time trends in OCI rates among different groups.CONCLUSION This review estimated high rates of OCI prevalence in M and E countries,especially among multi-transfused patients as well as patients with chronic liver diseases.
出处 《World Journal of Hepatology》 2021年第2期242-260,共19页 世界肝病学杂志(英文版)(电子版)
  • 相关文献

参考文献4

二级参考文献70

  • 1Bartenschlager R, Lohmann V. Replication of hepatitis C virus. J Gen Viro12000; 81:1631-1648.
  • 2Poenisch M, Bartenschlager R. New insights into structure and replication of the hepatitis C virus and clinical implica- tions. Semin Liver Dis 2010; 30:333-347.
  • 3Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995; 15:41-63.
  • 4Bostan N, Mahmood T. An overview about hepatitis C: a devastating virus. Crit Rev Microbio12010; 36:91-133.
  • 5Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5:558-567.
  • 6Alberti A, Chemello L, Benvegnh L. Natural history of hepatitis C. J Hepato11999; 31 Suppl 1:17-24.
  • 7Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepa- tology 2009; 49:1335-1374.
  • 8Pawiotsky JM, Lonjon I, Hezode C, Raynard B, Darthuy F, Remire J, Soussy CJ, Dhumeaux D. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 1998; 27:1700-1702.
  • 9Castillo I, Pardo M, Bartolome J, Ortiz-Movilla N, Rodri- guez-Ifiigo E, de Lucas S, Salas C, Jimenez-Heffernan JA, Perez-Mota A, Graus J, Lopez-Alcorocho JM, Carreno V. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004; 189:7-14.
  • 10Radkowski M, Horban A, Gallegos-Orozco JF, Pawelczyk A,Jablonska J, Wilkinson J, Adair D, Laskus T. Evidence for vi- ral persistence in patients who test positive for anti-hepatitis C virus antibodies and have normal alanine aminotransfer- ase levels. J Infect D~s 2005; 191:1730-1733.

共引文献15

同被引文献3

引证文献1

  • 1Donatien Serge Mbaga,Sebastien Kenmoe,Jacky Njiki Bikoï,Guy Roussel Takuissu,Marie Amougou-Atsama,Etienne Atenguena Okobalemba,Jean Thierry Ebogo-Belobo,Arnol Bowo-Ngandji,Martin Gael Oyono,Jeannette Nina Magoudjou-Pekam,Ginette Irma Kame-Ngasse,Alex Durand Nka,Alfloditte Flore Feudjio,Cromwel Zemnou-Tepap,Elie Adamou Velhima,Juliette Laure Ndzie Ondigui,Rachel Audrey Nayang-Mundo,Sabine Aimee Touangnou-Chamda,Yrene Kamtchueng Takeu,Jean Bosco Taya-Fokou,Chris Andre Mbongue Mikangue,Raoul Kenfack-Momo,Cyprien Kengne-Ndé,Carole Stephanie Sake,Seraphine Nkie Esemu,Richard Njouom,Lucy Ndip,Sara Honorine Riwom Essama.Global prevalence of occult hepatitis C virus: A systematic review and meta-analysis[J].World Journal of Methodology,2022,12(3):179-190.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部